Drug Type Small molecule drug |
Synonyms FMU200 |
Target |
Mechanism JNK3 inhibitors(c-Jun N-terminal kinase 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neurodegenerative Diseases | Preclinical | BR | 02 Apr 2021 |